Preparation and Characterization of Gastroreten-tive Sustained Release In-situ Gel of Lafutidine
DOI:
https://doi.org/10.37285/ijpsn.2022.15.6.4Abstract
Background: The in-situ solutions, which float in the gastrointestinal region after gelation, is suited for long-term drug release. In this study, natural and synthetic polymers were used to try to build a Gastro-Retentive controlled release in-situ gel. To modulate the rate of drug distribution and increase bioavailability and stability, gastro-retentive controlled release in-situ gels were prepared.
Materials and Methods: For this project, 32 factorial designs were chosen. The two independent variables were sodium alginate (X1) and the ratio of HPMC K100M: Gellan Gum (X2) was preserved at the same concentration. As the study mentioned, sodium alginate is a natural polymer that is employed to build the gel matrix, while HPMC K100M and gellan gum serve as release retardants.
Results and Discussion: The drug and excipients study performed by FTIR and DSC revealed that both the drug and polymers used were compatible with other. Out of all the batches prepared LG7 proved to be the optimized batch because of the acceptable pH with a floating time of more than 24 hours and maximum drug content of 99.92 ± 0.04% and the lag time of 71 ± 0.57seconds. The viscosity of the optimized batch was found to be dependent on the concentration of sodium alginate and the viscosity before gelling and after gelling was found to be 32719 ± 1.65 and 39851 ± 1.77 cps. The mucoadhesion strength of the prepared optimized formulation was found to be 5.621 ± 0.41N/cm2. The optimized LG7 batch showed the most sustained rate of drug release with having a matrix model as the best-fitted model. The histopathology study revealed that the formulation was safe to use without causing any degeneration of the tissues. The stability study showed that the prepared formulation was stable for the time of the study as no significant changes were observed. Lastly, the sustained behavior of the prepared in-situ gel was due to the calcium carbonate in the gelling formulation which released carbon dioxide into the gastrointestinal environment, and the formulation became porous and buoyant, extending the residence period and the floating of the gel was due to the pH-induced ion gelation process that caused the gel to float.
Conclusion: It was concluded that the prepared controlled release in-situ gel of Lafutidine may prove to be a potential candidate for safe and effective controlled drug delivery for an extended period.
Downloads
Metrics
Keywords:
Gastro-retentive In situ Gel, Lafutidine, Mucoadhesive Oral In- situ gel, ANOVA, Factorial design, GERD
Downloads
Published
How to Cite
Issue
Section
References
Abou Youssef NA, Kassem AA, Magda Abd Elsamea EM, Boraie NA. Development of gastroretentive metronidazole floating raft system for targeting Helicobacter pylori. International journal of pharmaceutics. 2015 May 30;486(1-2):297-305.
Ahmed MG, Kapoor C, Sanjana A. Formulation and evaluation of oral sustained in-situ gelling system of roxatidine. Indonesian Journal of Pharmacy. 2017 Aug 3;28(3):178.
Bashir R, Majeed A, Ali T, Farooq S, Khan NA. Floating oral in-situ gel: a review. Journal of Drug Delivery and Therapeutics. 2019 Mar 15;9(2):442-8.
Bisht N, Goswami L, Kothiyal P. Preparation and evaluation of in-situ oral topical gel of levofloxacin by using combination of polymers. Indian J Drugs. 2014;2(4):142-51.
Branch SK. Guidelines from the international conference on harmonisation (ICH). Journal of pharmaceutical and biomedical analysis. 2005 Aug 10;38(5):798-805.
Chadha R, Bhandari S. Drug–excipient compatibility screening—role of thermoanalytical and spectroscopic techniques. Journal of pharmaceutical and biomedical analysis. 2014 Jan 18;87:82-97.
Das MK, Maurya DP. Evaluation of diltiazem hydrochloride-loaded mucoadhesive microspheres prepared by emulsification-internal gelation technique. Acta Pol Pharm. 2008 Mar 1;65(2):249-59.
Darandale SS, Vavia PR. Design of a gastroretentive mucoadhesive dosage form of furosemide for controlled release. Acta Pharmaceutica Sinica B. 2012 Oct 1;2(5):509-17.
Galgatte UC, Kumbhar AB, Chaudhari PD. Development of in-situ gel for nasal delivery: design, optimization, in-vitro and in vivo evaluation. Drug delivery. 2014 Feb 1;21(1):62-73.
Gulecha BS, Shahi S, Lahoti SR. Floating in-situ gelling drug delivery system of verapamil hydrochloride. American Journal of Pharm Tech Research. 2012;2(4):954-69.
Higuchi T. Mechanism of sustained‐action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. Journal of pharmaceutical sciences. 1963 Dec;52(12):1145-9.
Jani BR, Shah KV, Kapupara PP. Development and validation of UV spectroscopic method for simultaneous estimation of dapagliflozin and metformin hydrochloride in synthetic mixture. International Journal of Research and Development in Pharmacy and Life Sciences. 2015 Apr;4(3):1569-76.
Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanisms of solute release from porous hydrophilic polymers. International journal of pharmaceutics. 1983 May 1;15(1):25-35.
Mahmoud DB, Shukr MH, ElMeshad AN. Gastroretentive cosolvent-based in-situ gel as a promising approach for simultaneous extended delivery and enhanced bioavailability of mitiglinide calcium. Journal of Pharmaceutical Sciences. 2019 Feb 1;108(2):897-906.
Maraie NK, Almajidi YQ. Application of nanoemulsion technology for preparation and evaluation of intranasal mucoadhesive nano-in-situ gel for ondansetron HCl. Journal of Global Pharma Technology. 2018;10(03):431-2.
Nagarwal RC, Srinatha A, Pandit JK. In-situ forming formulation: development, evaluation, and optimization using 33 factorial design. Aaps Pharmscitech. 2009 Sep;10(3):977-84.
Onodera S, Shibata M, Tanaka M, Inaba N, Yamaura T, Ohnishi H. Gastroprotective activity of FRG-8813, a novel histamine H2-receptor antagonist, in rats. The Japanese Journal of Pharmacology. 1995;68(2):161-73.
Pandya K, Aggarwal P, Dashora A, Sahu D, Garg R, Pareta LK, Menaria M, Joshi B. Formulation and evaluation of oral floatable in-situ gel of ranitedine hydrochloride. Journal of Drug Delivery and Therapeutics. 2013 May 13;3(3):90-7.
Patel MJ, Patel KR, Patel MR, Patel NM. Strategy for development of pH triggered floating in-situ gel of Levetiracetam. Am J Pharm Tech Res. 2012;2(3):828-41.
Pathan IB, Chudiwal V, Farooqui I, Shingare P. Formulation design and evaluation of nasal in-situ gel as a novel vehicle for azelastine hydrochloride. International Journal of Drug Delivery. 2013 Jul 1;5(3):284.
Patil S, Talele GS. Gastroretentive mucoadhesive tablet of lafutidine for controlled release and enhanced bioavailability. Drug delivery. 2015 Apr 3;22(3):312-9.
Sabareesh M, Yanadaiah JP, Sekhar KB. Formulation development, Ex vivo evaluation and In vivo antihypertensive study of losartan potassium loaded nanoproniosomal gel: A novel vesicular approach for transdermal delivery. Research Journal of Pharmacy and Technology. 2021;14(3):1423-30.
Sarkar D, Nandi G, Changder A, Hudati P, Sarkar S, Ghosh LK. Sustained release gastroretentive tablet of metformin hydrochloride based on poly (acrylic acid)-grafted-gellan. International journal of biological macromolecules. 2017 Mar 1;96:137-48.
Shivaraju SP, Senthilkumar SK. Preparation and evaluation of ornidazole in-situ gelling system for gastroretentive drug delivery. International Journal of Pharmacy. 2013;3(2):62-9.
Patil S, Talele GS. Gastroretentive mucoadhesive tablet of lafutidine for controlled release and enhanced bioavailability. Drug delivery. 2015 Apr 3;22(3):312-9.
Thomas LM. Formulation and evaluation of floating oral in-situ gel of metronidazole. Int J Pharm Pharm Sci. 2014;6(10):265-9.
Ur-Rehman T, Tavelin S, Gröbner G. Chitosan in-situ gelation for improved drug loading and retention in poloxamer 407 gels. International journal of pharmaceutics. 2011 May 16;409(1-2):19-29.
Zatz JL, Woodford DW. Prolonged release of theophylline from aqueous suspensions. Drug Development and Industrial Pharmacy. 1987 Jan 1;13(12):2159-78.
